Acute-Phase Concentrations of Lipopolysaccharide (LPS)-Binding Protein Inhibit Innate Immune Cell Activation by Different LPS Chemotypes via Different Mechanisms
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The chain length of bacterial lipopolysaccharide (LPS) is a crucial factor for host-pathogen interaction during bacterial infection. While rough (R)-type and smooth (S)-type LPSs have been shown to differ in their ability to interact with the bactericidal/permeability-increasing protein, little is known about the differential mode of interaction with the acute-phase reactant LPS-binding protein (LBP). At lower concentrations, LBP catalyzes the binding of LPS to CD14 and enhances LPS-induced cellular activation via Toll-like receptor 4. In humans, however, concentrations of LBP in serum increase during an acute-phase response, and these LBP concentrations exhibit inhibitory effects in terms of cellular activation. The mechanisms of inhibition of LPS effects by LBP are not completely understood. Here, we report that human high-dose LBP (hd-LBP) suppresses binding of both R-type and S-type LPS to CD14 and inhibits LPS-induced nuclear translocation of NF-κB, although cellular uptake of R-type LPS was found to be increased by hd-LBP. In contrast, we found that hd-LBP enhanced the binding and uptake of S-type LPS only under serum-free conditions, whereas in the presence of serum, hd-LBP inhibited cellular binding and uptake. This inhibitory effect of serum could be mimicked by the addition of purified high-density lipoprotein (HDL) to serum-free medium, indicating an LBP-mediated transfer of preferentially S-type LPS to plasma lipoproteins such as HDL. A complete understanding of the host's mechanisms to modulate the proinflammatory effects of LPS will most likely help in the understanding of inflammation and infection and may lead to novel therapeutic intervention strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Opal, S. M., Scannon, P. J., Vincent, J., White, M., Carroll, S. F., Palardy, J. E., Parejo, N. A., Pribble, J. P., & Lemke, J. H. (1999) · The Journal of Infectious Diseases · doi:10.1086/315093 · Cited by 609 · cited 1×
“Normal concentrations of LBP in human serum range between 5 and 10 g/ml and are strongly increased during an acute-phase response by up to 200 g/ml (3, 32, 46).”
BackgroundWurfel, M. M., Kunitake, S. T., Lichenstein, H., Kane, J. P., & Wright, S. D. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.3.1025 · Cited by 442 · cited 2×
“Currently discussed mechanisms thought to be involved in this inhibitory activity are the ability of LBP to transport LPS into HDL particles (27, 39, 43) and, according to a more recent study, the detachment of LPS from mCD14 and the inhibition of LPS transfer from CD14 to MD-2 (38).”
BackgroundResult
Cited by
Alcoholic liver disease and the gut-liver axis
Szabo, G. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i11.1321 · Cited by 378
The role of lipopolysaccharide-induced cell signalling in chronic inflammation
Page, M. J., Kell, D. B., & Pretorius, E. (2022) · Chronic Stress · doi:10.1177/24705470221076390 · Cited by 315
The Main Aeromonas Pathogenic Factors
Tomás, J. M. (2012) · ISRN Microbiology · doi:10.5402/2012/256261 · Cited by 314
Acute Binge Drinking Increases Serum Endotoxin and Bacterial DNA Levels in Healthy Individuals
Bala, S., Marcos, M., Gattu, A., Catalano, D., & Szabo, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096864 · Cited by 311
“LBP and sCD14 are both LPS-inducible protective molecules and are considered as ‘‘acute phase reactants’’ [18].”
BackgroundEndotoxemia—menace, marker, or mistake?
Munford, R. S. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ru0316-151r · Cited by 219
“At the high plasma concentrations reached in sick patients [144], LBP may inhibit cellular responses to LPS [145], even after the LPS has bound host cells [146] (LBP can also prevent LPS from activating LAL [132]).”
Background
Metadata
- Authors
- Hamann, L., Alexander, C., Stamme, C., Zähringer, U., & Schumann, R. R.
- Venue
- Infection and Immunity
- Publisher
- American Society for Microbiology
- Published
- 2005-01
- Volume
- 73
- Issue
- 1
- Pages
- 193-200
- ISSN
- 0019-9567 (ISSN-L)
- 1098-5522
- OpenAlex
- W2166108529
- Cited by
- 71
- References
- 2
- FWCI
- 1.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Acute-Phase Concentrations of Lipopolysaccharide (LPS)-Binding Protein Inhibit Innate Immune Cell Activation by Different LPS Chemotypes via Different Mechanisms. https://app.cochat.ai/papers/10.1128/iai.73.1.193-200.2005
- The paper
- Hamann, L., Alexander, C., Stamme, C., Zähringer, U., & Schumann, R. R. (2005). Acute-Phase Concentrations of Lipopolysaccharide (LPS)-Binding Protein Inhibit Innate Immune Cell Activation by Different LPS Chemotypes via Different Mechanisms. Infection and Immunity. https://doi.org/10.1128/iai.73.1.193-200.2005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.